In parallel, CRISPR/Cas9 gene editing has enabled integration of the CAR cassette into the CCR5 locus, conferring resistance of T cells to HIV infection and reducing the risk of virus-mediated depletion [80,81]. The gene discussed is CCR5; the disease is HIV infectious disease.